Metrika

  • citati u SCIndeksu: 0
  • citati u CrossRef-u:0
  • citati u Google Scholaru:[]
  • posete u poslednjih 30 dana:8
  • preuzimanja u poslednjih 30 dana:6

Sadržaj

članak: 9 od 14  
Back povratak na rezultate
2020, vol. 17, br. 1, str. 8-13
Faktori rizika i komorbiditeti koji predisponiraju fibrilaciju atrija
Dom zdravlja, Krupa na Uni, Republika Srpska, Bosna i Hercegovina

e-adresamarijanajandrickocic@gmail.com
Sažetak
Cilj. Fibrilacija atrija (lat.fibrillatio atriorum, FA) predstavlja najčešću aritmiju u kličkoj praksi kojom je pogođeno 1-2% svjetske populacije. Karakteriše je visokofrekventna ekscitacija atrija, posljedična asinhron a atrijalna kontrakcija i nepravilna ekscitacijaventrikula. Faktori rizika i komorbiditeti predisponiraju FA promjenom ekstracelularnog matiksa, promjenom funkcije fibroblasta i masnih stanica, jonskih kanala, miocita, autonomnog nervnog sistema, endotelnim i vaskularnim promjenama. Istraživanje je imalo za cilj utvrditi faktore rizika i komorbiditete koji su statistički značajno povezani sa pojavom FA. Metode. Istraživanje je studija presjeka obavljeno u Domu zdravlja Krupa na Uni u periodu od 01. 11. 2017. do 01.01.2019. Podaci su prikupljeni putem anamneze, fizikalnog pregleda, elektrokardiograma, laboratorijske dijagnostike, ultrazvučnog pregleda i dostupne medicinske dokumentacije. Obrada podataka vršena je standardnim statističkim metodama. Rezultati. Studija je uključila 145 slučajno odabranih pacijenata, 96 (66.2%) žena i 49 (33.8%) muškaraca., prosječne starosti 63±9.8 godina. FA je učestalija kod žena, starijih od 60 godina i osoba koje konzumiraju alkohol (p<0.05). Komorbiditeti povezani sa FA su: hipertrofija lijeve komore, mitralna regurgitacija, hipertenzija, dijabetes, hronična opstruktivna bolest pluća i gojaznost (p<0.05). Zaključak. Rana detekcija, pravovremen i adekvatan menadžment komorbiditeta i faktora rizika FA sprečava ili usporava napredovanja FA, podiže kvalitet života oboljelih, smanjenjuje troškove zadravstvene zaštite i radnog apsentizma.
Reference
Aksnes, T.A., Schneider, M.P., Kjeldsen, S.E., Wachtell, K., Schmieder, R.E. (2009) Atrial fibrillation and renin-angiotensin system blockade in hypertension. European Cardiology Review, 5(2): 63-8
Ambrosi, C.M., Yamada, K.A., Nerbonne, J.M., Efimov, I.R. (2013) Gender differences in electrophysiological gene expression in failing and non-failing human hearts. PLoS One, 8(1): e54635-e54635
Aronow, W.S. (2017) Hypertension associated with atrial fibrillation. Annals of Translational Medicine, 5(23): 457
Benčić-Lovrić, M. (2016) Fibrilacija atrija - najčešća postojana aritmija. Kardiologija danas, 25: 167-76
Bohne, L.J., Johnson, D., Rose, R.A., Wilton, S.B., Gillis, A.M. (2019) The association between diabetes mellitus and atrial fibrillation: Clinical and mechanistic insights. Frontiers in Physiology, 10: 135
Brandes, A., Smit, M.D., Nguyen, B.O., Rienstra, M., van Gelder, I.C. (2018) Risk factor management in atrial fibrillation. Arrhythm Electrophysiol Rev, 7: 118-27
Chen, X., Lin, M., Wang, W., Nalliah, C.J., Sanders, P., Kottkamp, H., Kalman, J.M. (2016) The progression in atrial fibrillation patients with COPD: A systematic review and meta-analysis. Oncotarget, 8(60):102420-102427, dostupno na:10.18632/oncotarget.22092
Dzeshka, M.S., Shahid, F., Shantsila, A., Lip, G.Y.H. (2017) Hypertension and atrial fibrillation: An intimate association of epidemiology, pathophysiology, and outcomes. American Journal of Hypertension, 30(8): 733-755
Ferreira, J.P., Santos, M. (2015) Heart failure and atrial fibrillation: From basic science to clinical practice. International Journal of Molecular Sciences, 16(2): 3133-3147
Grigioni, F., Avierinos, J.F., Ling, L.H., Scott, C.G., Bailey, K.R., Tajik, A., Frye, R.L., Enriquez-Sarano, M. (2002) Atrial fibrillation complicating the course of degenerative mitral regurgitation: Determinants and long-term outcome. Journal of the American College of Cardiology, 40(1): 84-92
Grymonprez, M., Vakaet, V., Kavousi, M., Stricker, B.H., Ikram, M., Heeringa, J., Franco, O.H., Brusselle, G.G., Lahousse, L. (2019) Chronic obstructive pulmonary disease and the development of atrial fibrillation. International Journal of Cardiology, 276: 118-124
Hayami, N., Sekiguchi, A., Iwasaki, Y.K., Murakawa, Y., Yamashita, T. (2016) No additional effect of DPP-4 inhibitor on preventing atrial fibrosis in streptozotocin-induced diabetic rat as compared with sulfonylurea. International Heart Journal, 57(3): 336-340
Hsueh, W., Abel, E., Breslow, J.L., Maeda, N., Davis, R.C., Fisher, E.A., Dansky, H., McClain, D.A., McIndoe, R., Wassef, M.K., Rabada'n-Diehl, C., Goldberg, I.J. (2007) Recipes for creating animal models of diabetic cardiovascular disease. Circulation Research, 100(10): 1415-1427
Ionin, V., Zaslavskaya, E.L., Belyaeva, O.D., Soboleva, A.V., Bazhenova, E.A., Jatzuk, D.I., Nifontov, S.E., Polyakova, E.A., Baranova, E.I., Shlyachto, E.V. (2016) New risk factors for atrial fibrillation in patients with hypertension and obesity. Journal of Hypertension, 34: e23-e23
Kim, E.J., Lyass, A., Wang, N., Massaro, J.M., Fox, C.S., Benjamin, E.J., Magnani, J.W. (2013) Relation of hypothyroidism and incident atrial fibrillation (from the Framingham heart study). American Heart Journal, 167(1): 123-126
Kolettis, T.M., Tsatsoulis, A. (2012) Subclinical hypothyroidism: An overlooked cause of atrial fibrillation?. J Atr Fibrillation, 5: 710
Krittayaphong, R., Rangsin, R., Thinkhamrop, B., Hurst, C., Rattanamongkolgul, S., Sripaiboonkij, N., Yindeengam, A. (2016) Prevalence and associating factors of atrial fibrillation in patients with hypertension: A nation-wide study. BMC Cardiovascular Disorders, 16(1): 57
Lavie, C., Pandey, A., Lau, D.H., Alpert, M.A., Sanders, P. (2017) Obesity and atrial fibrillation prevalence, pathogenesis, and prognosis: Effects of weight loss and exercise. J Am Coll Cardiol, 70: 2022-2057
Lin, Y.K., Chen, Y.A., Lee, N., Chen, Y.A., Chen, S.A., Chen, Y.A. (2018) Aging modulates the substrate and triggers remodeling in atrial fibrillation. Circulation Journal, 82(5): 1237-1244
Mashat, A.A., Subki, A.H., Bakhaider, M.A., Baabdullah, W.M., Walid, J.B., Alobudi, A.H., Fakeeh, M.M., Algethmi, D.A.J., Alhejily, W.A. (2019) Atrial fibrillation: Risk factors and comorbidities in a tertiary center in Jeddah, Saudi Arabia. International Journal of General Medicine, Volume 12: 71-77
Nalliah, C.J., Sanders, P., Kottkamp, H., Kalman, J.M. (2016) The role of obesity in atrial fibrillation. Eur Heart J, 37: 1565-72
Seko, Y., Kato, T., Haruna, T., Izumi, T., Miyamoto, S., Nakane, E., Inoko, M. (2018) Association between atrial fibrillation, atrial enlargement, and left ventricular geometric remodeling. Scientific Reports, 8(1): 6366-6366
Selmer, C., Olesen, J.B., Hansen, M.L., Lindhardsen, J., Olsen, A., Madsen, J.C., Faber, J., Hansen, P.R., Pedersen, O.D., Torp-Pedersen, C., Gislason, G.H. (2012) The spectrum of thyroid disease and risk of new onset atrial fibrillation: A large population cohort study. BMJ, 345(nov27 1): e7895
Shah, V., Desai, T., Agrawal, A. (2016) The association between chronic obstructive pulmonary disease (copd) and atrial fibrillation: A review. Chronic Obstructive Pulmonary Disease: Open Access, 1: 2
Suo, Y., Zhang, Z., Fu, H., Zhang, Y., Yuan, M., Wang, Y., Goudis, C.A., Tse, G., Liu, T., Li, G. (2018) Inhibition of renin-angiotensin axis reduces the risk of thrombus formation in the left atrial appendage in patients with hypertension complicated by atrial fibrillation. Journal of the Renin-Angiotensin-Aldosterone System, 19(2): 147032031878262-147032031878262
Suzuki, S., Otsuka, T., Sagara, K., Kano, H., Matsuno, S., Takai, H., Kato, Y., Uejima, T., Oikawa, Y., Nagashima, K., Kirigaya, H., Kunihara, T., Yajima, J., Sawada, H., Aizawa, T., Yamashita, T. (2015) Association between smoking habits and the first-time appearance of atrial fibrillation in Japanese patients: Evidence from the Shinken database. Journal of Cardiology, 66(1): 73-79
Tadić, M., Cuspidi, C. (2015) Type 2 diabetes mellitus and atrial fibrillation: From mechanisms to clinical practice. Archives of Cardiovascular Diseases, 108(4): 269-276
Velagić, V. (2017) Inducibilost paroksizmalne fibrilacije atrija nakon krioablacije plućnih vena. Zagreb: Sveučilište u Zagrebu-Medicinski fakultet, Disertacija, http://medlib.mef.hr/3079/1/Velagi%C4%87-DIS-2017.pdf
Voskoboinik, A., Prabhu, S., Ling, L.H., Kalman, J.M., Kistler, P.M. (2016) Alcohol and atrial fibrillation: A sobering review. J Am Coll Cardiol, 68(23): 2567-76
Williams, B., Mancia, G., Spiering, W., et al. (2018) ESC/ESH guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European society of cardiology and the European society of hypertension: The task force for the management of arterial h. J Hypertens, 36: 1953-2041
 

O članku

jezik rada: srpski
vrsta rada: izvorni naučni članak
DOI: 10.5937/pomc17-23451
primljen: 02.10.2019.
prihvaćen: 22.09.2020.
objavljen u SCIndeksu: 06.01.2021.

Povezani članci

Nema povezanih članaka